[HTML][HTML] Cancer cervix: Epidemiology and disease burden
S Pimple, G Mishra - Cytojournal, 2022 - ncbi.nlm.nih.gov
Cervical cancer remains a major public health problem, ranking as the fourth most common
cause of cancer incidence and mortality in women worldwide. Wide variations in cervical …
cause of cancer incidence and mortality in women worldwide. Wide variations in cervical …
Human papillomavirus and cervical cancer
M Schiffman, PE Castle, J Jeronimo, AC Rodriguez… - The lancet, 2007 - thelancet.com
Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …
2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors
RB Perkins, RS Guido, PE Castle… - Journal of lower …, 2020 - journals.lww.com
Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …
[HTML][HTML] Worldwide burden of cervical cancer in 2008
Background The knowledge that persistent human papillomavirus infection is the main
cause of cervical cancer has resulted in the development of assays that detect nucleic acids …
cause of cervical cancer has resulted in the development of assays that detect nucleic acids …
[HTML][HTML] Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
B Serrano, S de Sanjosé, S Tous, B Quiros… - European journal of …, 2015 - Elsevier
Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution …
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution …
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
ML Gillison, AK Chaturvedi, DR Lowy - Cancer, 2008 - Wiley Online Library
Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the
basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is …
basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is …
The landscape of viral expression and host gene fusion and adaptation in human cancer
Abstract Viruses cause 10–15% of all human cancers. Massively parallel sequencing has
recently proved effective for uncovering novel viruses and virus–tumour associations, but …
recently proved effective for uncovering novel viruses and virus–tumour associations, but …
[PDF][PDF] Human papillomavirus and HPV vaccines: a review
FT Cutts, S Franceschi, S Goldie… - Bulletin of the World …, 2007 - SciELO Public Health
Cervical cancer, the most common cancer affecting women in developing countries, is
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
N Muñoz, SK Kjaer, K Sigurdsson… - Journal of the …, 2010 - academic.oup.com
Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …
Age-specific prevalence of infection with human papillomavirus in females: a global review
JS Smith, A Melendy, RK Rana, JM Pimenta - Journal of Adolescent Health, 2008 - Elsevier
PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …